<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical findings of POEMS syndrome</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical findings of POEMS syndrome</h1>
<div class="graphic"><div class="figure"><div class="ttl">Clinical findings of POEMS syndrome</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Characteristic</td> <td class="subtitle1_left">% Affected*</td> </tr> <tr> <td><strong>Polyneuropathy</strong></td> <td>100</td> </tr> <tr class="highlight_sub2_gray_text"> <td><strong>Organomegaly</strong></td> <td>45 to 85</td> </tr> <tr class="highlight_sub2_gray_text"> <td> <ul class="decimal_heading"> <li>Hepatomegaly</li> </ul> </td> <td>23 to 78</td> </tr> <tr class="highlight_sub2_gray_text"> <td> <ul class="decimal_heading"> <li>Splenomegaly</li> </ul> </td> <td>22 to 70</td> </tr> <tr class="highlight_sub2_gray_text"> <td> <ul class="decimal_heading"> <li>Lymphadenopathy</li> </ul> </td> <td>26 to 74</td> </tr> <tr class="highlight_sub2_gray_text"> <td> <ul class="decimal_heading"> <li>Castleman disease</li> </ul> </td> <td>11 to 25</td> </tr> <tr> <td><strong>Endocrinopathy</strong></td> <td>67 to 89</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Gonadal axis abnormality</li> </ul> </td> <td>55 to 89</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Adrenal axis abnormality</li> </ul> </td> <td>16 to 33</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Increased prolactin value</li> </ul> </td> <td>5 to 20</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Gynecomastia or galactorrhea</li> </ul> </td> <td>12 to 18</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Diabetes mellitus</li> </ul> </td> <td>3 to 36</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Hypothyroidism</li> </ul> </td> <td>9 to 67</td> </tr> <tr class="highlight_sub2_gray_text"> <td><strong>Monoclonal plasma cell dyscrasia</strong><sup>¶</sup></td> <td>100</td> </tr> <tr class="highlight_sub2_gray_text"> <td> <ul class="decimal_heading"> <li>M-protein on serum protein electrophoresis</li> </ul> </td> <td>24 to 55</td> </tr> <tr> <td><strong>Skin changes</strong></td> <td>68 to 93</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Hyperpigmentation</li> </ul> </td> <td>25 to 93</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Acrocyanosis and plethora</li> </ul> </td> <td>19 to 46</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Hemangioma/telangiectasia</li> </ul> </td> <td>9 to 35</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Hypertrichosis</li> </ul> </td> <td>20 to 74</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Thickening</li> </ul> </td> <td>5 to 43</td> </tr> <tr class="highlight_sub2_gray_text"> <td><strong>Papilledema</strong></td> <td>29 to 64</td> </tr> <tr> <td><strong>Extravascular volume overload</strong></td> <td>29 to 89</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Peripheral edema</li> </ul> </td> <td>24 to 89</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Ascites</li> </ul> </td> <td>6 to 54</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Pleural effusion</li> </ul> </td> <td>3 to 43</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Pericardial effusion</li> </ul> </td> <td>1 to 64</td> </tr> <tr class="highlight_sub2_gray_text"> <td><strong>Bone lesions</strong></td> <td>27 to 97</td> </tr> <tr> <td><strong>Thrombocytosis</strong></td> <td>34 to 88</td> </tr> <tr class="highlight_sub2_gray_text"> <td><strong>Polycythemia</strong></td> <td>12 to 19</td> </tr> <tr> <td><strong>Clubbing</strong></td> <td>5 to 49</td> </tr> <tr class="highlight_sub2_gray_text"> <td><strong>Decreased DLCO</strong></td> <td>&gt;15</td> </tr> <tr> <td><strong>Pulmonary hypertension</strong></td> <td>36</td> </tr> <tr class="highlight_sub2_gray_text"> <td><strong>Weight loss &gt;10 lb</strong></td> <td>37 to 41</td> </tr> <tr> <td><strong>Fatigue</strong></td> <td>22 to 31</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>POEMS: polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes; DLCO: diffusing capacity of carbon monoxide.</p>
<p>* Percentages are based on the total number of patients in the series.</p>
¶ In both the Takasuki and Nakanishi series, only 75% of patients had a documented plasma cell disorder, which defies the current definition for POEMS syndrome. As these are among the earliest series describing the syndrome, they are included.</div><div class="graphic_reference">References:
<ol>
<li>Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol 1983; 13:543.</li>
<li>Nakanishi T, Sobue I, Toyokura Y, et al. The crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984; 34:712.</li>
<li>Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French study group on POEMS syndrome. Am J Med 1994; 97:543.</li>
<li>Li J, Zhou DB, Huang Z, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol 2011; 90:819.</li>
<li>Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003; 101:2496.</li>
<li>Ghandi GY, Basu R, Dispenzieri A, et al. Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc 2007; 82:836.</li>
<li>Keddie S, Foldes D, Caimari F, et al. Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study. Neurology 2020; 95:e268.</li>
</ol></div><div id="graphicVersion">Graphic 140981 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
